Ubs Group Ag Morphic Holding, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$26.12 - $34.07 $2.81 Million - $3.66 Million
-107,534 Reduced 72.17%
41,460 $1.41 Million
Q1 2024

May 13, 2024
BUY
$26.64 - $40.31 $1.5 Million - $2.28 Million
56,441 Added 60.98%
148,994 $5.24 Million
Q4 2023

Feb 09, 2024
BUY
$19.95 - $31.0 $965,659 - $1.5 Million
48,404 Added 109.64%
92,553 $2.67 Million
Q3 2023

Nov 09, 2023
BUY
$21.33 - $59.42 $547,455 - $1.53 Million
25,666 Added 138.86%
44,149 $1.01 Million
Q2 2023

Aug 11, 2023
BUY
$34.33 - $62.11 $617,219 - $1.12 Million
17,979 Added 3567.26%
18,483 $1.06 Million
Q1 2023

May 12, 2023
SELL
$26.01 - $48.69 $354,802 - $664,180
-13,641 Reduced 96.44%
504 $18,000
Q4 2022

Feb 08, 2023
BUY
$24.14 - $30.37 $341,460 - $429,583
14,145 New
14,145 $378,000
Q2 2022

Aug 10, 2022
SELL
$19.74 - $43.01 $26,708 - $58,192
-1,353 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$36.25 - $52.02 $49,046 - $70,383
1,353 New
1,353 $54,000
Q4 2021

Feb 14, 2022
SELL
$43.27 - $65.72 $1.2 Million - $1.83 Million
-27,819 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$53.61 - $67.5 $1.36 Million - $1.71 Million
25,348 Added 1025.82%
27,819 $1.58 Million
Q2 2021

Aug 13, 2021
BUY
$45.13 - $64.99 $81,324 - $117,111
1,802 Added 269.36%
2,471 $142,000
Q1 2021

May 12, 2021
SELL
$29.77 - $84.85 $65,553 - $186,839
-2,202 Reduced 76.7%
669 $42,000
Q4 2020

Feb 11, 2021
SELL
$25.66 - $34.55 $203,278 - $273,705
-7,922 Reduced 73.4%
2,871 $96,000
Q3 2020

Nov 12, 2020
BUY
$22.51 - $30.11 $146,089 - $195,413
6,490 Added 150.83%
10,793 $295,000
Q2 2020

Jul 31, 2020
SELL
$12.65 - $29.57 $29,929 - $69,962
-2,366 Reduced 35.48%
4,303 $116,000
Q1 2020

May 01, 2020
SELL
$10.84 - $20.85 $17,701 - $34,048
-1,633 Reduced 19.67%
6,669 $98,000
Q4 2019

Feb 14, 2020
BUY
$13.02 - $19.5 $38,760 - $58,051
2,977 Added 55.91%
8,302 $142,000
Q3 2019

Nov 14, 2019
BUY
$17.46 - $29.05 $89,430 - $148,794
5,122 Added 2523.15%
5,325 $96,000
Q2 2019

Aug 14, 2019
BUY
$18.0 - $19.82 $3,654 - $4,023
203 New
203 $4,000

Others Institutions Holding MORF

# of Institutions
9
Shares Held
4.71M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email